Cargando…
Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
BACKGROUND: Bivalent thrombin‐binding aptamers (TBAs) have great potential for the treatment of thrombosis because they exhibit high anticoagulant activity, and their complementary single‐stranded DNA (ssDNA) sequences work as an antidote. However, a design strategy for antidote sequences against bi...
Autores principales: | Yoshitomi, Toru, Wakui, Koji, Miyakawa, Masato, Yoshimoto, Keitaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178692/ https://www.ncbi.nlm.nih.gov/pubmed/34136744 http://dx.doi.org/10.1002/rth2.12503 |
Ejemplares similares
-
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties
por: Hughes, Quintin W., et al.
Publicado: (2017) -
A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice
por: Nagano, Masanobu, et al.
Publicado: (2023) -
Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX
por: Wakui, Koji, et al.
Publicado: (2019) -
Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin
por: Martin, Jennifer A., et al.
Publicado: (2013) -
Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review
por: Torabi, Raheleh, et al.
Publicado: (2020)